Turning Innovation into Access
Getting a therapy approved is only the first step. Ensuring patients can access it is the real challenge. Komtur’s Market Access Solutions help pharma and biotech companies implement and scale pathways for real-world access.
From Early Access and Compassionate Use, to Patient Support Programs, we deliver managed and compliant solutions that enable continuity of care, accelerate time to therapy, and support market adoption. Our approach is built around each product’s access journey, whether following market withdrawal, supporting unlicensed use, or preparing for a phased launch. It integrates logistics, medical engagement, and real-world data collection. Komtur helps transform strategic access plans into tangible outcomes, creating a platform for patient reach and long-term market success.
Komtur’s Market Access Solutions are built to support pharma and biotech partners as they navigate the path from clinical readiness to real-world availability. This is particularly relevant for therapies addressing rare, serious, or unmet medical needs. We offer fully managed access models that combine compliant logistics, regulatory expertise, medical engagement, and stakeholder engagement into one integrated patient-centric solution. Komtur delivers the clarity, execution, and infrastructure needed to turn access strategy into measurable patient reach.
Core Services
Market Access ConsultingShaping access strategies for real-world success. We help translate market access strategies into operational reality. We advise on access model design, stakeholder engagement, distribution frameworks, and compliance infrastructure tailored to each product and region.
Managed Access ProgramStructured access. Centred on patients. From Early Access to Compassionate Use, we design and manage sponsor-driven programs that support ethical, compliant, and timely treatment access for patients in need. These programs are integrated into broader launch planning and tailored to each product’s access journey.
Patient Support ProgramEnabling continuity of care. Our tailored programs support patients throughout the treatment journey, from education and onboarding to coordination with healthcare providers and home care services. Designed in collaboration, our solutions are compliant, scalable, and always patient-focused.
Why Komtur
One Platform, Integrated Access
Komtur orchestrates access across regulatory, operational, stakeholder, and medical functions. We deliver Early Access, Compassionate Use, and Patient Support services in one sponsor-aligned, patient-centric solution.Lifecycle Continuity from Phase II to Post-Launch
Our models support access from first patient supply in Early or Compassionate Use through to commercialization. This enables agile launch sequencing and consistent patient continuity across stages.Global Reach with Local Adaptation
With 18 affiliates and deep regional expertise, we tailor implementation country by country. This helps ensure local realities don’t become global bottlenecks.Trusted in Complex Access Environments
Biotech and rare disease innovators rely on Komtur to bridge clinical readiness with operational access, even when data is limited or infrastructure is fragmented.Beyond Access: Supporting the Full Patient Journey
Our PSPs deliver education, coordination, and care continuity. We help patients start and stay on therapy while reinforcing outcomes and long-term treatment success.
Start your market access plan
Discuss access strategy, stakeholder engagement, and launch readiness with a Komtur specialist.